Type 2 Diabetes Modifies the Association of CAD Genomic Risk Variants With Subclinical Atherosclerosis
Manuscript ID: 16294
| Submitting Author |
Hasbani, Natalie
|
|---|---|
| Submitting Author's Email | |
| Authors |
Natalie R. Hasbani MPH1, Kenneth E. Westerman PhD2,3,4, Soo Heon Kwak MD5, Han Chen PhD1,6, Xihao Li PhD7, Daniel Dicorpo MS8, Jennifer Wessel PhD9, Joshua C. Bis PhD10, Chloè Sarnowski PhD1, Peitao Wu PhD11, Lawrence F. Bielak DDS12, Xiuqing Guo PhD13, Nancy Heard-Costa PhD14, Gregory Kinney PhD15, Michael C Mahaney PhD16, May E. Montasser PhD17, Nicholette D. Palmer PhD18, Laura M. Raffield PhD19, James G. Terry MS20, Lisa R. Yanek MPH21, Jessica Bon MD22, Donald W. Bowden PhD18, Jennifer A. Brody BA10, Ravindranath Duggirala PhD23, David R. Jacobs PhD24, Rita R. Kalyani MD21, Leslie A. Lange PhD25, Braxton D. Mitchell PhD17,26, Jennifer A. Smith PhD12,27, Kent D. Taylor PhD13, April Carson PhD28, Joanne E Curran PhD16, Myriam Fornage PhD29, Barry I. Freedman MD30, Stacey Gabriel PhD31, Richard A Gibbs PhD32, Namrata Gupta PhD31, Sharon L.R. Kardia PhD12, Brian G. Kral MD21, Zeineen Momin MS32, Anne B. Newman MD33, Wendy S. Post MD34, Karine A. Viaud-Martinez35, Kendra A. Young PhD15, Lewis C. Becker MD21, Alain Bertoni MD, MPH36, John Blangero PhD16, John J. Carr MD20, Katherine Pratte, PhD37, Bruce M. Psaty MD, PhD38,39,40, Stephen S. Rich PhD41, NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium, TOPMed Atherosclerosis Working Group, TOPMed Diabetes Working Group, Joesph C. Wu MD, PhD42,43,44, Rajeev Malhotra MD45, Patricia A. Peyser PhD12, Alanna C Morrison PhD1, Ramachandran S. Vasan MD46,47, Xihong Lin PhD7, Jerome I. Rotter MD48, James B. Meigs MD49,4,50, Alisa K. Manning PhD2,3,4, Paul S. de Vries PhD1
|
| Journal name for most current submission |
Circulation: Genomic and Precision Medicine
|
| Associated TOPMed paper proposal | |
| This manuscript has been approved by the original paper proposal's Working Group(s) or is "single PI" * |
This manuscript has been approved by the original paper proposal's Working Group(s) or is "single PI"
|
| Acknowledgments |
I have followed instructions for TOPMed Acknowledgments
|
| I've received approval for all data sets used in this manuscript, including adding new data sets and canceling all unused ones. * |
I've received approval for all data sets used in this manuscript, including adding new data sets and canceling all unused ones.
|
| I have followed the Data Use Limitations for each of the data sets used in this manuscript, if applicable. * |
Yes
|
| I've included at least 1 co-author from each study used in analysis or the PI declined an offer to have their study represented. * |
Yes
|
| I certify that all co-authors have reviewed and approved the manuscript for submission. * |
Yes
|
| I've included at least 1 DCC/ACC author, or they declined authorship or deemed acknowledgement sufficient. |
I've included at least 1 DCC/ACC author, or they declined authorship or deemed acknowledgement sufficient.
|
| I’ve included at least 1 IRC author, or they declined authorship or deemed acknowledgement sufficient. |
I’ve included at least 1 IRC author, or they declined authorship or deemed acknowledgement sufficient.
|
| I've included at least 1 author from relevant omics center(s) or they declined authorship or deemed acknowledgement sufficient. |
I've included at least 1 author from relevant omics center(s) or they declined authorship or deemed acknowledgement sufficient.
|
TOPMed data used in this manuscript
The data set approvals listed here should match the TOPMed data used in this manuscript.
Don't see all the data sets you need? Request more data sets at any time.
Please "cancel" any data set requests that were not used in this manuscript. Note: only the paper proposal submitter or their designated updater can cancel data sets.
| Parent Study: Consent Group | Review Status | Actions |
|---|---|---|
| ARIC:DS-CVD-IRB | Approved | |
| ARIC:HMB-IRB | Approved | |
| Amish:HMB-IRB-MDS | Approved automatically after 2 weeks | |
| CARDIA:HMB-IRB | Approved automatically after 2 weeks | |
| CARDIA:HMB-IRB-NPU | Approved automatically after 2 weeks | |
| CHS:DS-CVD-MDS | Approved | |
| CHS:DS-CVD-NPU-MDS | Approved | |
| CHS:HMB-MDS | Approved | |
| CHS:HMB-NPU-MDS | Approved | |
| COPDGene:DS-CS-RD | Approved | |
| COPDGene:HMB | Approved | |
| DHS:DS-DHD-IRB-COL-NPU | Approved | |
| DHS:HMB-IRB-COL-NPU | Approved | |
| FHS:HMB-IRB-MDS | Approved automatically after 2 weeks | |
| FHS:HMB-IRB-NPU-MDS | Approved automatically after 2 weeks | |
| GENOA:DS-ASC-RF-NPU | Approved | |
| GeneSTAR:DS-CVD-IRB-NPU-MDS | Approved automatically after 2 weeks | |
| JHS:DS-FDO-IRB | Approved | |
| JHS:DS-FDO-IRB-NPU | Approved | |
| JHS:HMB-IRB | Approved | |
| JHS:HMB-IRB-NPU | Approved | |
| MESA:HMB | Approved | |
| MESA:HMB-NPU | Approved | |
| SAFS:DS-DHD-IRB-PUB-MDS-RD | Approved |
Back to top
